Expert attacks decision in US to stop use of bevacizumab for eye condition

Source: British Medical Journal (BMJ)
Area: News
A leading specialist has criticised the US Department of Veterans Affairs' decision to stop using bevacizumab (Avastin®) for wet age related macular degeneration (AMD), due to a possible increased risk of infection (see previous NeLM report at the link below).    According to a report by the British Medical Journal (BMJ), Philip Rosenfeld of the University of Miami told the New York Times that the recent incidents seemed to have stemmed from careless procedures by pharmacies and should not discourage the use of (Read more...)

Full Story →